TD Cowen Maintains Hold on P3 Health Partners, Lowers Price Target to $4
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsPrice Target
TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and lowers the price target from $13 to $4.
TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and lowers the price target from $13 to $4.